Access to Investigational Drugs is Now Available
February 18, 2005
The National Institute of Health now offers a question and answer fact sheet regarding access to investigational drugs. An investigational drug is one that is being studied and has yet to be approved by the U.S. Food and Drug Administration (FDA). The fact sheet also discusses risks, cost, and resources pertaining to investigational drugs.
Because the majority of drugs used in the treatment of cancer are initially developed for adults, they are considered investigational drugs when being tested on children. As a result, pediatric cancer patients often utilize clinical trials. It is important for them to have information on investigational drugs and know how to access them. Getting this information to patients has been a goal for cancer advocate groups such as Children’s Cause for Cancer Advocacy. For more information on the fact sheet, visit the National Cancer Institute
<< Back
February 18, 2005
The National Institute of Health now offers a question and answer fact sheet regarding access to investigational drugs. An investigational drug is one that is being studied and has yet to be approved by the U.S. Food and Drug Administration (FDA). The fact sheet also discusses risks, cost, and resources pertaining to investigational drugs.
Because the majority of drugs used in the treatment of cancer are initially developed for adults, they are considered investigational drugs when being tested on children. As a result, pediatric cancer patients often utilize clinical trials. It is important for them to have information on investigational drugs and know how to access them. Getting this information to patients has been a goal for cancer advocate groups such as Children’s Cause for Cancer Advocacy. For more information on the fact sheet, visit the National Cancer Institute
<< Back
